Cargando…
Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics
BACKGROUND: Significant intertumoral heterogeneity exists as antitumor treatment is introduced. Heterogeneous therapeutic responses are conventionally evaluated by imaging examinations based on Response Evaluation Criteria in Solid Tumors (RECIST); nevertheless, there are increasing recognitions tha...
Autores principales: | Lv, Jiawei, Wu, Chenfei, Li, Junyan, Chen, Foping, He, Shiwei, He, Qingmei, Zhou, Guanqun, Ma, Jun, Sun, Ying, Wei, Denghui, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396864/ https://www.ncbi.nlm.nih.gov/pubmed/35996151 http://dx.doi.org/10.1186/s12916-022-02463-5 |
Ejemplares similares
-
Refined characterization of circulating tumor DNA through biological feature integration
por: Markus, Havell, et al.
Publicado: (2022) -
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study
por: Fu, Rui, et al.
Publicado: (2023) -
Refining colorectal cancer classification and clinical stratification through a single-cell atlas
por: Khaliq, Ateeq M., et al.
Publicado: (2022) -
Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlas
por: Khaliq, Ateeq M., et al.
Publicado: (2022) -
Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)